Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vyndaqel Capsules Special Investigation - Investigation on Patients With Transthyretin Amyloid Cardiomyopathy

NCT04108091 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04108091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04108091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vyndaqel Capsules Special Investigation - Investigation on Patients With Transthyretin Amyloid Cardiomyopathy
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 3, 2019
Completion date
March 27, 2025
Enrollment
1,214 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin (ttr) amyloid cardiomyopathy